M. Cotton, A. Violari, and K. Otwombe, Early time-limited antiretroviral therapy versus deferred therapy in 176

J. Ananworanich, A. Schuetz, and C. Vandergeeten, Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection, PLoS ONE, vol.355, issue.3, p.33948, 2012.
DOI : 10.1371/journal.pone.0033948.t002

N. Archin, N. Vaidya, and J. Kuruc, Immediate antiviral therapy appears to restrict resting CD4+ cell
DOI : 10.1073/pnas.1120248109
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386138

O. Lambotte, F. Boufassa, and Y. Madec, HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication, Clinical Infectious Diseases, vol.41, issue.7, pp.1053-1056, 2005.
DOI : 10.1086/433188

A. Sáez-cirión, C. Bacchus, and L. Hocqueloux, Post-treatment HIV-1 controllers with a long-term virological 186 remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study, PLoS Pathog, vol.187, issue.9, p.1003211, 2013.

D. Persaud, K. Patel, and B. Karalius, Influence of Age at Virologic Control on Peripheral Blood Human Immunodeficiency Virus Reservoir Size and Serostatus in Perinatally Infected Adolescents, JAMA Pediatrics, vol.168, issue.12, pp.1138-1146, 2014.
DOI : 10.1001/jamapediatrics.2014.1560

K. Luzuriaga, B. Tabak, and M. Garber, HIV Type 1 (HIV-1) Proviral Reservoirs Decay Continuously Under 192
DOI : 10.1093/infdis/jiu297
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215073

J. Ananworanich, T. Puthanakit, and P. Suntarattiwong, Reduced markers of HIV persistence and restricted 195

P. Frange, A. Faye, and V. Avettand-fenoël, HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report, The Lancet HIV, vol.3, issue.1, pp.49-54, 2016.
DOI : 10.1016/S2352-3018(15)00232-5
URL : https://hal.archives-ouvertes.fr/pasteur-01289420

J. Overbaugh and L. Morris, The Antibody Response against HIV-1. Cold Spring Harb Perspect Med, pp.201-007039, 2012.
DOI : 10.1101/cshperspect.a007039
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253031

P. Burbelo, A. Bayat, and C. Rhodes, HIV Antibody Characterization as a Method to Quantify Reservoir Size During Curative Interventions, Journal of Infectious Diseases, vol.209, issue.10, pp.1613-1617, 2014.
DOI : 10.1093/infdis/jit667
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997576

M. Zanchetta, A. Anselmi, and D. Vendrame, Early therapy in HIV-1-infected children, p.1

H. Payne, N. Mkhize, and K. Otwombe, Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysis, The Lancet Infectious Diseases, vol.15, issue.7, pp.803-809, 2015.
DOI : 10.1016/S1473-3099(15)00087-0

L. Kuhn, D. Schrall, and S. Shiau, Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed, AIDS, vol.29, issue.9, pp.1053-1060, 2015.
DOI : 10.1097/QAD.0000000000000677

V. Avettand-fènoël, M. Chaix, and S. Blanche, LTR real-time PCR for HIV-1 DNA quantitation in blood cells 215 for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01), J Med, vol.216

F. Barin, L. Meyer, and R. Lancar, Development and validation of an immunoassay for identification of 218 recent human immunodeficiency virus type 1 infections and its use on dried serum spots, J Clin Microbiol, vol.219, issue.43, pp.4441-4447, 2005.

K. Luzuriaga, M. Mcmanus, and C. M. , Early therapy of vertical human immunodeficiency virus type 1

S. Deeks, S. Lewin, and A. Ross, International AIDS Society global scientific strategy: towards an HIV cure 2016, Nature Medicine, vol.1, issue.8, pp.839-850, 2016.
DOI : 10.1038/nature10003
URL : https://hal.archives-ouvertes.fr/hal-01355203